Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Endologix: Is Covidien Itching To Buy?
Seeking Alpha
Friday, November 15, 2013 - 10:11am
tags:
Covidien, devices, Endologix, M&A
Cadence: Best Case Outcome On Ofirmev Patent Litigation
Seeking Alpha
Friday, November 15, 2013 - 9:55am
tags:
Cadence Pharmaceuticals, Ofirmev, patents, Exela Pharma Sciences
Summer Street doubts FDA will approve Xiaflex on December 6 PDUFA
The Fly on the Wall
Friday, November 15, 2013 - 9:54am
tags:
FDA, Xiaflex, Peyronie's Disease
Eteplirsen in Question: Hope for Sarepta
Motley Fool
Friday, November 15, 2013 - 9:51am
tags:
eteplirsen, Sarepta Therapeutics, Duchenne Muscular Dystrophy
Profit bonanza eludes companies chasing obesity business
Reuters
Friday, November 15, 2013 - 9:42am
tags:
obesity, diabetes, Novo Nordisk, Arena Pharmaceuticals, Vivus
Merck KGaA invests $107 million in China drug plant
Yahoo/Reuters
Friday, November 15, 2013 - 9:39am
tags:
Merck KGaA, drug manufacturing, China
AstraZeneca, Generic Drugmakers Face Class Action on Nexium
Bloomberg/Businessweek
Friday, November 15, 2013 - 9:36am
tags:
generics, Class Action Lawsuit, AstraZeneca, Nexium, Teva
BioMarin's Morquio A drug confers "modest" benefit -FDA review
Yahoo/Reuters
Friday, November 15, 2013 - 9:04am
tags:
Biomarin, Morquio A Syndrome, FDA, Vimizim
Kimberly-Clark Plans to Spin Off Health-Care Business
Bloomberg
Friday, November 15, 2013 - 8:49am
tags:
devices, Kimberly-Clark
Baxter, Cell Therapeutics announce collaboration to develop pacritinib
Yahoo/Fly on the Wall
Friday, November 15, 2013 - 8:43am
tags:
Baxter International, pacritinib, Cell Therapeutics, JAK2/FLT3 inhibitors, solid tumors, myelofibrosis
Zafgen drug helps patients lose up to 24 pounds
Yahoo/Reuters
Friday, November 15, 2013 - 8:42am
tags:
Zafgen, beloranib, obesity
DARA: Building An Oncology And Supportive Care Specialty Pharma
Yahoo/Zacks.com
Friday, November 15, 2013 - 8:40am
tags:
DARA Biosciences, oncology, earnings
FDA says new cholesterol drugs may not need outcome studies
Yahoo/Reuters
Friday, November 15, 2013 - 8:37am
tags:
FDA, cholesterol, PCSK9 inhibitors, statins, Pfizer, Amgen, Sanofi, Regeneron
Pfizer Ditching BlackBerry, Citing Its ‘Volatile’ State
Bloomberg
Thursday, November 14, 2013 - 5:53pm
tags:
Pfizer, Blackberry
Anacor Rises on Positive Data
Yahoo/Zacks.com
Thursday, November 14, 2013 - 5:52pm
tags:
Anacor, atopic dermatitis, AN2728
U.S. FDA panel backs Vanda's circadian rhythm drug
Yahoo/Reuters
Thursday, November 14, 2013 - 5:50pm
tags:
FDA, advisory panels, Vanda, non-24 hour disorder, tasimelteon
Merck Raises 2013 Profit Forecast on Speed of Cost Cuts
Bloomberg
Thursday, November 14, 2013 - 12:10pm
tags:
Merck, guidance
Trio of IPO setbacks strike sour note at biotech's Wall Street party
Fierce Biotech
Thursday, November 14, 2013 - 11:06am
tags:
biotech, IPOs, Relypsa, Xencor, Celladon
Merck May Lose Out From New Treatment Guide For Cholesterol
Seeking Alpha
Thursday, November 14, 2013 - 11:02am
tags:
Merck, statins, cholesterol, Zetia
Key Takeaways From Arena's Third-Quarter Update
Motley Fool
Thursday, November 14, 2013 - 11:00am
tags:
earnings, Arena Pharmaceuticals, Belviq, Eisai

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.